Bristol Myers Squibb Stock Investor Sentiment

BMY Stock  USD 60.42  0.34  0.57%   
Slightly above 52% of Bristol Myers' investor base is interested to short. The analysis of overall sentiment of trading Bristol Myers Squibb stock suggests that many investors are impartial at this time. Bristol Myers' investing sentiment can be driven by a variety of factors including economic data, Bristol Myers' earnings reports, geopolitical events, and overall market trends.
  
a minute ago at seekingalpha.com         
Ascent Industries sells Bristol Metals for 45M
seekingalpha News
a minute ago at fortune.com         
Hawaii court orders Bristol Myers Squibb and Sanofi to pay the state 916m in Plavix blood thinner la...
news
a day ago at zacks.com         
Bristol Myers Squibb Ascends But Remains Behind Market Some Facts to Note
zacks News
2 days ago at aol.com         
Premiership to trial separate away sections for fans in upcoming fixtures
news
2 days ago at bbc.co.uk         
Harry Thacker Kieran Marmion Bristol hooker and scrum-half sign new deals
news
3 days ago at patch.com         
New Bristol Eatery Draws Crowds
patch News
3 days ago at insidermonkey.com         
Bristol-Myers Squibb Company A Bull Case Theory
insidermonkey News
3 days ago at patch.com         
Bristol Animal Shelter Holding Rabies Clinic This Weekend
patch News
few days ago at thelincolnianonline.com         
Bristol-Myers Squibb Shares Sold by Choate Investment Advisors
news
few days ago at bbc.co.uk         
Four Palestine Action members arrested after Bristol protest
news
few days ago at bbc.co.uk         
Acquisition by Plenge Robert M of 2342 shares of Bristol Myers subject to Rule 16b-3
news
few days ago at aol.com         
Nightclubs closure likely despite cash backing
news
few days ago at insidermonkey.com         
Why Bristol-Myers Squibb Company Went Down On Thursday?
insidermonkey News
few days ago at bbc.co.uk         
Bristol City George Tanner undergoes knee surgery
news
few days ago at bbc.co.uk         
Northern soul enjoys a revival among young people in Bristol
news
Far too much social signal, news, headlines, and media speculation about Bristol Myers that are available to investors today. That information is available publicly through Bristol media outlets and privately through word of mouth or via Bristol internal channels. However, regardless of the origin, that massive amount of Bristol data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bristol Myers news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bristol Myers relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bristol Myers' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bristol Myers alpha.

Bristol Myers Performance against Dow Jones

 Price Growth (%)  
       Timeline  
 
Bristol Myers dividend paid on 3rd of February 2025
02/03/2025

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.